While clinical data for PD-1KO CAR Tregs are not yet available, preclinical studies have shown that these cells maintain Foxp3 expression and suppressive function for at least three weeks post-transfer in a xenogeneic graft-versus-host disease (xenoGVHD) model.64 Here, FOXP3 is linked to graft versus host disease.